Evidence map›Paper›PMID 23280879›Full record

ArticleLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2013

In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs.

James E Fisher, Joseph B Lillegard, Travis J McKenzie, Brian R Rodysill, Peter J Wettstein, Scott L Nyberg

Open access · bronzeAbstract read
In one paragraph

Article in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Limited Expansion of Human Hepatocytes in FAH/Tissue engineering. Part A · 2022
    Article
  3. Genetically engineered pigs for xenotransplantation: Hopes and challenges.Frontiers in cell and developmental biology · 2022
    Review
  4. Review
  5. Article
  6. Genetically Engineered Pigs to Study Cancer.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Cell therapy in chronic liver disease.Current opinion in gastroenterology · 2016
    Review
  12. Engineered Swine Models of Cancer.Frontiers in genetics · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cellular therapy for liver disease.Mayo Clinic proceedings · 2014
    Review
  18. Article
  19. Article
  20. In utero hepatocellular transplantation in rats.Clinical & developmental immunology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

James E FisherDivision of Transplant Surgery, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Joseph B Lillegard
Travis J McKenzie
Brian R Rodysill
Peter J Wettstein
Scott L Nyberg
Mayo Clinic in Arizona · US

Funding

XENOGENEIC BIOARTIFICAL LIVERR01DK056733 · NIDDK · MAYO CLINIC ROCHESTER · PI NYBERG, SCOTT L · 1999 to 2010
$1.4M
NIDDK NIH HHS R01 DK056733NIDDK NIH HHS R01-DK56733
6 · The paper itself

Abstract

In utero cell transplantation (IUCT) can lead to the postnatal engraftment of human cells in the xenogeneic recipient. Most reports of IUCT have involved hematopoietic stem cells. It is unknown whether human hepatocytes used for IUCT in fetal pigs will lead to the engraftment of these same cells in the postnatal environment. In this study, fetal pigs received direct liver injections of 1 × 10(7) human hepatocytes in utero and were delivered by cesarean section at term. The piglets received a second direct liver injection of 5 × 10(7) human hepatocytes 1 week after birth. The serum was analyzed for human albumin 2, 4, and 6 weeks after engraftment. Piglet livers were harvested 6 weeks after transplantation and were examined by immunohistochemistry, polymerase chain reaction, and fluorescence in situ hybridization for human-specific sequences. Piglets undergoing IUCT with human hepatocytes that were postnatally engrafted with human hepatocytes showed significant levels of human albumin production in their serum at all postengraftment time points. Human albumin gene expression, the presence of human hepatocytes, and the presence of human beta-2 microglobulin were all confirmed 6 weeks after engraftment. IUCT in fetal pigs with human hepatocytes early in gestation allowed the engraftment of human hepatocytes, which remained viable and functional for weeks after transplantation. IUCT followed by postnatal engraftment may provide a future means for large-scale expansion of human hepatocytes in genetically engineered pigs.

Indexed as

AnimalsAnimals, Newbornbeta 2-MicroglobulinBiomarkersCell SurvivalFemaleGene Expression RegulationGestational AgeHepatocytesHumansImmunohistochemistryInjectionsIn Situ Hybridization, FluorescenceLiverPregnancyReverse Transcriptase Polymerase Chain ReactionALB protein, humanbeta 2-MicroglobulinBiomarkersSerum AlbuminSerum Albumin, Human

Identifiers

PMID23280879
PMCPMC3600116
OpenAlexW1516071742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.